doi: 10.1037/a0037223
A molecule that blocks the receptors activity normalized social behaviors and flexibility in spatial learning in a mouse model of dup15q syndrome
I have experience in successfully treating patients with varying diagnoses in rehab, outpatient, acute, and home health settings
Which medications belong to the class FDA-approved GLP-1 receptor agonists as of April 2026 include exenatide (Byetta, Bydureon), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), lixisenatide (historically, now discontinued in the U.S.), and semaglutide (Ozempic, Wegovy, Rybelsus)
So I think this is a story of both products being used in combination and providing great outcomes and outcome benefits. Lets go a little deeper into each of these categories